| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1734-1140(10)70317-0 |
| P698 | PubMed publication ID | 20885000 |
| P50 | author | Marian Jędrych | Q83728137 |
| P2093 | author name string | Kinga K Borowicz | |
| Radosław Zarczuk | |||
| Dariusz Łukasik | |||
| P2860 | cites work | Therapeutic efficacy and adverse effects of adrenocorticotropic hormone therapy in west syndrome: differences in dosage of adrenocorticotropic hormone, onset of age, and cause | Q83219953 |
| Potassium channel antibodies in two patients with reversible limbic encephalitis | Q28206692 | ||
| Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis | Q28245345 | ||
| Glutamate receptor GluR3 antibodies and death of cortical cells | Q28261256 | ||
| Rapid decrease of GAD 67 content before the convulsion induced by hyperbaric oxygen exposure | Q28569424 | ||
| Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome | Q30447900 | ||
| Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures | Q33336296 | ||
| Possible induction of systemic lupus erythematosus by valproate | Q33393041 | ||
| Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase | Q33744544 | ||
| Syndrome of acquired aphasia with convulsive disorder in children | Q33969521 | ||
| Epilepsy and the immune system | Q34103932 | ||
| Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis | Q34332988 | ||
| Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients | Q34342831 | ||
| Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement | Q34390601 | ||
| Cytokine dysregulation, inflammation and well-being. | Q34451481 | ||
| Autoimmune channelopathies and related neurological disorders | Q34571467 | ||
| The use of immunoglobulins in the treatment of human epilepsy | Q34658387 | ||
| The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation | Q34669832 | ||
| The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation | Q34669837 | ||
| Role of cytokines in neurological disorders | Q35181196 | ||
| Corticosteroids in the management of the paediatric epilepsies | Q35283109 | ||
| Epilepsy and the immune system: is there a link? | Q36035130 | ||
| Brain inflammation in epilepsy: experimental and clinical evidence | Q36319367 | ||
| Early onset Rasmussen's syndrome: a malignant, often bilateral form of the disorder | Q36528117 | ||
| Refractory epilepsy: clinical overview | Q36742732 | ||
| Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy | Q36793709 | ||
| Role of brain inflammation in epileptogenesis | Q37040824 | ||
| Hypersensitivity to lamotrigine and nonaromatic anticonvulsant drugs: a review | Q37320466 | ||
| Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases | Q37634846 | ||
| Plasmapheresis in Rasmussen's encephalitis | Q70894664 | ||
| An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside | Q71511175 | ||
| Interleukin-2 as a neuroregulatory cytokine | Q71528891 | ||
| Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients | Q71683342 | ||
| Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients | Q72131553 | ||
| Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons | Q72350707 | ||
| High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study | Q72389832 | ||
| Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy | Q72764696 | ||
| Interleukin-1alpha in the brain is induced by audiogenic seizure | Q73394356 | ||
| Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors | Q73567957 | ||
| Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy | Q73986186 | ||
| Epilepsy associated with lupus anticoagulant | Q74129748 | ||
| Systemic lupus erythematosus and myoclonic epileptic manifestations | Q74137484 | ||
| Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures | Q74233667 | ||
| Intraventricular interferon-alpha stops seizures in Rasmussen's encephalitis: a case report | Q74526113 | ||
| Peripheral benzodiazepine receptor expression on leukocytes and neutrophil function during anticonvulsant monotherapy | Q77216788 | ||
| Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy | Q77730465 | ||
| Interleukin-1alpha, interleukin-1beta, and interleukin-1Ra polymorphisms in febrile seizures | Q81207471 | ||
| No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3--antibodies | Q83169241 | ||
| A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome). | Q39349754 | ||
| Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies | Q40088086 | ||
| Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome | Q41196484 | ||
| Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site | Q41354036 | ||
| Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system | Q42486510 | ||
| Convulsions induced by methylmalonic acid are associated with glutamic acid decarboxylase inhibition in rats: a role for GABA in the seizures presented by methylmalonic acidemic patients? | Q42618606 | ||
| Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile | Q42621543 | ||
| Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis | Q44066377 | ||
| Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures | Q44233555 | ||
| GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid | Q44301369 | ||
| Prednisone therapy in pediatric epilepsy | Q44456121 | ||
| Antiepileptogenic and anticonvulsant activity of interleukin-1 beta in amygdala-kindled rats. | Q45181326 | ||
| Choline acetyltransferase, glutamic acid decarboxylase and somatostatin in the kainic acid model for chronic temporal lobe epilepsy | Q45208224 | ||
| Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors | Q46456146 | ||
| GluR3 subunit regulates sleep, breathing and seizure generation | Q46724026 | ||
| Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. | Q46818702 | ||
| Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus | Q46821650 | ||
| Serum antibodies in epilepsy and seizure-associated disorders | Q46848031 | ||
| GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole | Q46975028 | ||
| Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration | Q47274535 | ||
| Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. | Q47801338 | ||
| Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis | Q48111449 | ||
| Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders | Q48220936 | ||
| Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes | Q48245672 | ||
| Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion | Q48288647 | ||
| Antiserum to brain gangliosides produces recurrent epileptiform activity | Q48350462 | ||
| A role of autoimmunity in the etiopathogenesis of Landau-Kleffner syndrome? | Q48443234 | ||
| Antibodies to voltage-gated potassium and calcium channels in epilepsy | Q48462110 | ||
| An association between mesial temporal lobe epilepsy with hippocampal sclerosis and human leukocyte antigens | Q48654693 | ||
| Treatment of infantile spasms with intravenous gamma-globulins | Q48663995 | ||
| Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels | Q48665627 | ||
| The role of TNF-alpha in amygdala kindled rats | Q48686169 | ||
| Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome | Q48717750 | ||
| Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report | Q48743511 | ||
| Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy? | Q48911721 | ||
| Immunological model of epilepsy. Epileptiform activity induced by fragments of antibody to GM1 ganglioside | Q48919137 | ||
| Autoimmunity to munc-18 in Rasmussen's encephalitis. | Q49110443 | ||
| Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. | Q50944728 | ||
| Epileptiform activity evoked by intracerebral injection of anti-brain antibodies | Q51121328 | ||
| Short-duration ACTH therapy for cryptogenic West syndrome with better outcome. | Q52000466 | ||
| Epileptic seizures in systemic lupus erythematosus | Q57086591 | ||
| Autoantibodies to the Glutamate Receptor Kill Neurons via Activation of the Receptor Ion Channel | Q63761923 | ||
| Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. | Q64902232 | ||
| Immunological studies in focal epilepsy | Q67233433 | ||
| Serologic HLA typing in infantile spasms | Q67969731 | ||
| Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy | Q68003063 | ||
| Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome | Q68179418 | ||
| Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome | Q68520517 | ||
| The effect of exogenous GM1 ganglioside on kindled-amygdaloid seizures | Q69034089 | ||
| Effects of antiepileptic drugs on concentration of serum proteins and immunoglobulins of epileptic patients | Q70015959 | ||
| P433 | issue | 4 | |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 592-607 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Pharmacological Reports | Q15766499 |
| P1476 | title | Immunological aspects of epilepsy | |
| P478 | volume | 62 |
| Q104479026 | Association between antiseizure medication use and risk of urinary tract infection: A case-control study |
| Q48162924 | Central effect of crocin on penicillin-induced epileptiform activity in rats |
| Q42485917 | Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication |
Search more.